Tolerance of two brands of praziquantel. (Record no. 2575527)

MARC details
000 -LEADER
fixed length control field 01258 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512005751.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198909s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0140-6736
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0140-6736(89)90572-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Homeida, M M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19890911
245 00 - TITLE STATEMENT
Title Tolerance of two brands of praziquantel.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Lancet (London, England)
Date of publication, distribution, etc. Aug 1989
300 ## - PHYSICAL DESCRIPTION
Extent 391 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Letter; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Praziquantel
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Random Allocation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schistosoma mansoni
General subdivision isolation & purification
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schistosomiasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sudan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eltom, I A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sulaiman, S M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ali, H M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bennett, J L
773 0# - HOST ITEM ENTRY
Title Lancet (London, England)
Related parts vol. 2
-- no. 8659
-- p. 391
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0140-6736(89)90572-2">https://doi.org/10.1016/s0140-6736(89)90572-2</a>
Public note Available from publisher's website

No items available.